Review
Open access
Aug 2026
Menopausal insomnia as a modifiable node of dementia risk: Mechanistic insights and intervention strategies
A dual‐cohort, parallel‐group trial using neuronal pentraxin‐2 (NPTX2) as a surrogate endpoint holds promise for assessing the efficacy of ADRD prevention and risk reduction in this high‐risk population.
Wen-Jing Zhang, Xue-Xin Zheng, Teng-Hong Lian et al.
· Alzheimer's & Dementia · 0 citations